The medicines are produced at the Pharmasyntez-Tyumen plant, which is the only one in Russia that fully specializes in the production of hormonal drugs.

The appearance on the market of affordable, high-quality, domestic hormonal drugs is an important event both for the Russian health care system and for the whole country. Medicinal sovereignty requires the presence of domestic drugs on the pharmaceutical market, especially in such a priority issue as reproductive health. This explains the high interest shown by the medical community in the DlyaJens and PlaniJens hormonal drugs lines.

The event is a unique platform for obstetrician-gynecologist, neonatologists and representatives of related professions throughout the country in order to exchange experience, improve professional knowledge and receive relevant information both from leading specialists in the field of maternal and child health and from pharmaceutical manufacturers represented in Russia. 

The Pharmasyntez Group of Companies makes a significant contribution in the preservation and improvement of women reproductive health, thus increasing the country’s drug safety.